Structural characterization by mass spectrometry of native and recombinant human relaxin-Reference-Cited by-同舟云学术

Structural characterization by mass spectrometry of native and recombinant human relaxin

Published:1990-11 Issue:11 Volume:19 Page:655-664
ISSN:1052-9306
Container-title:Biological Mass Spectrometry
language:en
Short-container-title:Biol. Mass Spectrom.

Author:

Stults John T.,Bourell James H.,Canova-Davis Eleanor,Ling Victor T.,Laramee Gary R.,Winslow John W.,Griffin Patrick R.,Rinderknecht Ernst,Vandlen Richard L.

Publisher

Wiley

Subject

Molecular Medicine,Biochemistry,Spectroscopy

Reference50 articles.

1. in Relaxin: Physiology of Reproduction, ed. by et al. Raven Press, New York (1988).

2. Purification and characterization of porcine relaxin

3. Purification and Characterization of Rat Relaxin*

4. Structure of a genomic clone encoding biologically active human relaxin

5. Relaxin gene expression in human ovaries and the predicted structure of a human preprorelaxin by analysis of cDNA clones.

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular delivery of relaxin-2 mRNA as a potential treatment for kidney fibrosis;Materials Today Bio;2023-08

2. Synthetic short-chain peptide analogues of H1 relaxin lack affinity for the RXFP1 receptor and relaxin-like bioactivity. Clues to a better understanding of relaxin agonist design;Frontiers in Pharmacology;2022-08-11

3. Enhancing the Therapeutic Potential of Mesenchymal Stromal Cell-Based Therapies with an Anti-Fibrotic Agent for the Treatment of Chronic Kidney Disease;International Journal of Molecular Sciences;2022-05-27

4. Relaxin as an anti-fibrotic treatment: Perspectives, challenges and future directions;Biochemical Pharmacology;2022-03

5. Administration study of recombinant human relaxin‐2 in horse for doping control purpose;Drug Testing and Analysis;2020-01-13